Stockscreener 앱 받기
0.7167
4.44%
-0.0333
시간 외 거래:
.72
0.0033
+0.46%
Ekso Bionics Holdings Inc 주식(EKSO)의 최신 뉴스
Ekso Gains, While Gearing up for “AI for Good” - Baystreet.ca
Ekso Bionics to Showcase Its Device Technology in ‘AI for Good’ Webinar on Tuesday, November 19 - GlobeNewswire
Ekso Bionics Expert to Present on AI-Powered Exoskeletons in Medical Rehabilitation | EKSO Stock News - StockTitan
ARMISTICE CAPITAL, LLC Acquires New Stake in Ekso Bionics Holdin - GuruFocus.com
A Comprehensive Study Exploring Artificial Organs and Bionics - openPR
Ekso Bionics to Participate at the 15th Annual Craig-Hallum Alpha Select Conference - The Manila Times
Take Care Before Jumping Onto Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Even Though It's 27% Cheaper - Simply Wall St
Ekso Bionics stock hits 52-week low at $0.83 amid market challenges By Investing.com - Investing.com South Africa
Ekso Bionics stock hits 52-week low at $0.83 amid market challenges - Investing.com Australia
Ekso Bionics (NASDAQ:EKSO) Coverage Initiated at StockNews.com - Defense World
Ekso Bionics (NASDAQ:EKSO) Coverage Initiated by Analysts at StockNews.com - Defense World
Rehabilitation Robots Market Size, Trends, Growth, - openPR
StockNews.com Begins Coverage on Ekso Bionics (NASDAQ:EKSO) - Defense World
Lake Street Capital Has Lowered Expectations for Ekso Bionics (NASDAQ:EKSO) Stock Price - Defense World
Ekso Bionics Holdings Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Ekso Bionics reports lower Q3 sales amid optimism as Medicare reimbursements begin - North Bay Business Journal
H.C. Wainwright cuts Ekso Bionics target by 10%, maintains Buy on growth prospects - Investing.com India
Earnings call: Ekso Bionics announces mixed Q3 results, eyes future growth - Investing.com India
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q3 2024 Earnings Call Transcript - Insider Monkey
Boot Barn To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
Ekso Bionics (EKSO) Reports Q3 Loss, Misses Revenue Estimates - MSN
Ekso Bionics Holdings Inc (EKSO) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
Ekso Bionics: Q3 Earnings Snapshot - The Advocate
Ekso Bionics Announces Third Quarter 2024 Financial Results - GlobeNewswire
Ekso Bionics earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
Ekso Bionics Q3 2024 Earnings: EPS Beats Estimates at -$0.10, Re - GuruFocus.com
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Ekso Bionics (EKSO) to Release Quarterly Earnings on Monday - Defense World
Ekso Bionics (NASDAQ:EKSO) Now Covered by StockNews.com - Defense World
Ekso Bionics Holdings (STU:23E2) Forward Dividend Yield % : 0.00% (As of Oct. 23, 2024) - GuruFocus.com
Ekso Bionics to Report Third Quarter 2024 Financial Results on October 28, 2024 - The Manila Times
StockNews.com Initiates Coverage on Ekso Bionics (NASDAQ:EKSO) - Defense World
Exoskeleton Market Size to Hit USD 1863.61 Million by 2033 | Straits Research - GlobeNewswire Inc.
Ekso Indego Personal to be Featured on ‘Health Uncensored’ with Dr. Drew Pinsky - GlobeNewswire
Human Augmentation Market Report 2024 Highlighting Rising - openPR
Speech Pathology Services Market Outlook: 2023 the Year on a Positive Note | Benchmark Therapies Inc, Dynatronics Corporation, Ekso Bionics Holdings Inc, GF health Products, Inc – Cauverynews - Cauverynews
Ekso Bionics (NASDAQ:EKSO) Now Covered by Analysts at StockNews.com - Defense World
TNR, The Niche Research says :Global Wearable Robotic Exoskeleton Market is Expected to Expand at a CAGR of 44.3% (2024 to 2034). This Growth Projection Covers Segments Including Type, Application, Functionality, Technology, End User,Region - Yahoo Finance
Esperion CEO Sheldon Koenig sells shares worth over $26k By Investing.com - Investing.com Canada
Esperion CEO Sheldon Koenig sells shares worth over $26k - Investing.com
BofA Securities Downgrades Esperion Therapeutics Inc. (ESPR) to an Underperform from a Neutral - Knox Daily
Stock Performance Spotlight: Esperion Therapeutics Inc. (ESPR) Ends the Day at 1.76, Down by -7.85 - The Dwinnex
EMINOVA HOLDINGS INTERNATIONAL signed a 1.5 M USD FUND RAISING AGREEMENT for "BIOREL KIDS FUN FOAM’ product - EIN News
2.70%
3.32%
자본화:
|
볼륨(24시간):